Bass Investment

Bass Investment operates from Seoul as a venture capital firm founded by former technology executives, channeling that operating background into early-stage backing for platform services and inventive problem-solving teams across South Korea’s startup ecosystem. The firm gravitates toward digital health and tech-enabled care delivery within healthcare, sitting alongside its broader interest in software-driven business models. Limited public information is available regarding named partners, specific portfolio companies, or recent fund vintages, so founders should expect to confirm investment cadence and team composition directly with the firm.

Check sizes typically fall between 250,000 and 1 million dollars, sized for pre-seed, seed, and Series A rounds where capital can underwrite product-market fit work and initial commercial traction. Geography centers on South Korea, with the Seoul base anchoring sourcing and post-investment support. The firm is structured as a generalist VC rather than a healthcare specialist, which is worth weighing if a founder wants deep clinical or regulatory expertise inside the cap table.

The stated approach favors teams attempting hard, structural problems rather than incremental consumer plays, and the founder backgrounds of the partnership suggest a working empathy for early operating challenges. Founders who value a Korea-anchored network, comfort with platform business models, and patience through the messy pre-revenue period are likely to find the firm’s mandate well-aligned. Those needing deep healthcare regulatory navigation or substantial follow-on capacity at later stages should plan to syndicate accordingly. Initial conversations should probe specifically how the team supports go-to-market in the Korean market and what reserves are typically allocated for Series A participation.